Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

443 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Design of a phase 1/2 trial of intracoronary administration of AAV1/SERCA2a in patients with heart failure.
Hajjar RJ, Zsebo K, Deckelbaum L, Thompson C, Rudy J, Yaroshinsky A, Ly H, Kawase Y, Wagner K, Borow K, Jaski B, London B, Greenberg B, Pauly DF, Patten R, Starling R, Mancini D, Jessup M. Hajjar RJ, et al. Among authors: ly h. J Card Fail. 2008 Jun;14(5):355-67. doi: 10.1016/j.cardfail.2008.02.005. Epub 2008 May 27. J Card Fail. 2008. PMID: 18514926 Clinical Trial.
Reversal of cardiac dysfunction after long-term expression of SERCA2a by gene transfer in a pre-clinical model of heart failure.
Kawase Y, Ly HQ, Prunier F, Lebeche D, Shi Y, Jin H, Hadri L, Yoneyama R, Hoshino K, Takewa Y, Sakata S, Peluso R, Zsebo K, Gwathmey JK, Tardif JC, Tanguay JF, Hajjar RJ. Kawase Y, et al. Among authors: ly hq. J Am Coll Cardiol. 2008 Mar 18;51(11):1112-9. doi: 10.1016/j.jacc.2007.12.014. J Am Coll Cardiol. 2008. PMID: 18342232 Free article.
Advances in gene-based therapy for heart failure.
Ly HQ, Kawase Y, Hajjar RJ. Ly HQ, et al. J Cardiovasc Transl Res. 2008 Jun;1(2):127-36. doi: 10.1007/s12265-008-9022-4. Epub 2008 May 29. J Cardiovasc Transl Res. 2008. PMID: 20559907 Review.
AAV9.I-1c delivered via direct coronary infusion in a porcine model of heart failure improves contractility and mitigates adverse remodeling.
Fish KM, Ladage D, Kawase Y, Karakikes I, Jeong D, Ly H, Ishikawa K, Hadri L, Tilemann L, Muller-Ehmsen J, Samulski RJ, Kranias EG, Hajjar RJ. Fish KM, et al. Among authors: ly h. Circ Heart Fail. 2013 Mar;6(2):310-7. doi: 10.1161/CIRCHEARTFAILURE.112.971325. Epub 2012 Dec 27. Circ Heart Fail. 2013. PMID: 23271792 Free PMC article.
Gene therapy in the treatment of heart failure.
Ly H, Kawase Y, Yoneyama R, Hajjar RJ. Ly H, et al. Physiology (Bethesda). 2007 Apr;22:81-96. doi: 10.1152/physiol.00037.2006. Physiology (Bethesda). 2007. PMID: 17420300 Free article. Review.
Long-term cardiac-targeted RNA interference for the treatment of heart failure restores cardiac function and reduces pathological hypertrophy.
Suckau L, Fechner H, Chemaly E, Krohn S, Hadri L, Kockskämper J, Westermann D, Bisping E, Ly H, Wang X, Kawase Y, Chen J, Liang L, Sipo I, Vetter R, Weger S, Kurreck J, Erdmann V, Tschope C, Pieske B, Lebeche D, Schultheiss HP, Hajjar RJ, Poller WC. Suckau L, et al. Among authors: ly h. Circulation. 2009 Mar 10;119(9):1241-52. doi: 10.1161/CIRCULATIONAHA.108.783852. Epub 2009 Feb 23. Circulation. 2009. PMID: 19237664 Free PMC article.
In vivo tracking in cardiac stem cell-based therapy.
Hoshino K, Ly HQ, Frangioni JV, Hajjar RJ. Hoshino K, et al. Prog Cardiovasc Dis. 2007 May-Jun;49(6):414-20. doi: 10.1016/j.pcad.2007.02.005. Prog Cardiovasc Dis. 2007. PMID: 17498521 Review.
443 results